Revere Data™ Expands Biopharm & MedTech Coverage to Canada
Product Pipeline, Clinical Trial Status, and Relationship Data for Toronto Stock Exchange (TSX) Biopharm and MedTech Companies

New York, August 9, 2007 – Revere Data, LLC, a fast-growing research provider of datafeed, software, index and ETF services today announced a significant enhancement to its biopharmaceutical and medical technology coverage. In addition to all NYSE, NASDAQ, and AMEX companies, Revere customers now have access to timely and detailed product, partnership and competitor information for all 75 biotech, specialty pharma and medtech companies trading on the Toronto Stock Exchange (TSX).

Revere Data’s expanded coverage increases visibility into an industry with some of the Canada’s fastest growing companies, with a combined market capitalization of approximately C$19 billion. Revere covers over 750 medical device and biopharmaceutical companies listed on US exchanges.

“North America is the largest healthcare market in the world, characterized by rapid innovations and heavy R&D Investments,” noted Jeremy Zhou, Director of Healthcare for Revere Data. “By expanding our coverage, Revere now offers unprecedented visibility into the pipelines of all U.S. and Canadian biopharm and medtech companies, which will enable our customers to search and discover companies with potential blockbuster drugs or devices with greater efficiency and confidence.”

“This expanded coverage into the Canadian healthcare sector represents yet another step in helping our customers identify and execute their unique investment ideas,” said Kevin E. O’Brien, Chief Executive Officer of Revere Data. “Our belief is that by expanding our coverage into major international exchanges, we will continue to deliver significant values to our customers in their equity selection, portfolio construction, performance measurement, and risk management.”

Revere’s patented sector classification system, key business relationships, and Healthcare Events, are all available in datafeeds and through the company’s flagship Revere Research service. Customers include sell-side agency and proprietary traders, buy-side traders, hedge funds, portfolio managers, and equity analysts, along with professionals at major corporations looking for product information and competitive advantages.


Revere Data, LLC, is a leading provider of financial information services that help investors better understand the cornerstone of all great companies: the products and services they sell. Revere goes deep inside companies to search, discover and classify their products and services, focused lines of business, and key business relationships. The patented Revere Hierarchy™ classifies companies in nine times as many sectors as is commonly used by investment professionals on Wall Street, thereby delivering a more precise and deeper view of the market. Revere Relationships™ provides visibility into key customer, supplier, competitor and strategic partner relationships for thousands of publicly traded US companies. Revere offers a full suite of data, online research, and index services for the institutional investment community.


PR Contact: Bill Mendel
Company: Mendel Communications LLC
Phone: (212) 397-1030
E-mail: bill@mendelcommunications.com

Research Contact: Brian Hill, CFA
Title: Director, Research
Company: Revere Data, LLC
Phone: (866) 738-3739 x105
E-mail: bhill@reveredata.com